Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$3.16B |
| 2 |
Merck
MRK
|
+$2.72B |
| 3 |
SLB Ltd
SLB
|
+$1.62B |
| 4 |
Target
TGT
|
+$1.6B |
| 5 |
General Mills
GIS
|
+$930M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$2.81B |
| 2 |
Blackrock
BLK
|
+$2.57B |
| 3 |
US Bancorp
USB
|
+$1.84B |
| 4 |
M&T Bank
MTB
|
+$808M |
| 5 |
Huntington Bancshares
HBAN
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.45% |
| 2 | Financials | 11.9% |
| 3 | Healthcare | 10.6% |
| 4 | Consumer Discretionary | 9.01% |
| 5 | Industrials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Primis Financial Corp
FRST
$409M
| $625K | ﹤0.01% |
63,987
+4,645
| +8% | +$49.5K |
|
3002
Cardlytics
CDLX
$23.8M
| $620K | ﹤0.01% |
34,069
-6,186
| -15% | -$177K |
|
3003
Ranger Energy Services
RNGR
$371M
| $620K | ﹤0.01% |
43,682
+2,001
| +5% | +$32.4K |
|
3004
Aviat Networks
AVNW
$275M
| $618K | ﹤0.01% |
32,242
| – | – |
|
3005
Mistras Group
MG
$503M
| $616K | ﹤0.01% |
58,201
-45
| -0.1% | -$444 |
|
|
ZK
3006
DELISTED
Zeekr
ZK
| $615K | ﹤0.01% |
25,549
+4,811
| +23% | +$128K |
|
|
THRD
3007
DELISTED
Third Harmonic Bio
THRD
| $615K | ﹤0.01% |
177,165
+3,966
| +2% | +$19.2K |
|
3008
Pure Cycle
PCYO
$255M
| $614K | ﹤0.01% |
58,651
+39
| +0.1% | +$443 |
|
3009
Aquestive Therapeutics
AQST
$471M
| $611K | ﹤0.01% |
210,699
+30
| +0% | +$91 |
|
|
ONIT
3010
Onity Group
ONIT
$321M
| $610K | ﹤0.01% |
18,887
-99
| -0.5% | -$3.28K |
|
3011
Ocugen
OCGN
$434M
| $608K | ﹤0.01% |
860,244
| – | – |
|
3012
Energy Vault
NRGV
$546M
| $604K | ﹤0.01% |
868,954
-20,539
| -2% | -$31.6K |
|
|
PHLT
3013
DELISTED
Performant Healthcare Inc
PHLT
| $603K | ﹤0.01% |
203,813
+11,642
| +6% | +$30.2K |
|
|
MBCN
3014
DELISTED
Middlefield Banc Corp
MBCN
| $599K | ﹤0.01% |
21,437
+1,164
| +6% | +$30.4K |
|
|
EU
3015
enCore Energy
EU
$223M
| $599K | ﹤0.01% |
437,297
| – | – |
|
3016
State Street SPDR S&P Dividend ETF
SDY
$23.8B
| $595K | ﹤0.01% |
4,387
-1,097
| -20% | -$148K |
|
3017
Neumora Therapeutics
NMRA
$298M
| $593K | ﹤0.01% |
593,498
-110,656
| -16% | -$189K |
|
3018
USCB Financial Holdings
USCB
$413M
| $592K | ﹤0.01% |
31,912
+1,581
| +5% | +$29.5K |
|
3019
LifeMD
LFMD
$178M
| $590K | ﹤0.01% |
108,482
+4
| +0% | +$23 |
|
|
DM
3020
DELISTED
Desktop Metal, Inc.
DM
| $586K | ﹤0.01% |
119,358
-6,053
| -5% | -$15.7K |
|
3021
Viant Technology
DSP
$246M
| $585K | ﹤0.01% |
47,166
+1
| +0% | +$18 |
|
3022
Seres Therapeutics
MCRB
$48.4M
| $584K | ﹤0.01% |
41,705
-1,586
| -4% | -$24.8K |
|
3023
Park-Ohio Holdings
PKOH
$599M
| $580K | ﹤0.01% |
26,831
+1,385
| +5% | +$33.2K |
|
3024
Alico
ALCO
$283M
| $578K | ﹤0.01% |
19,369
+184
| +1% | +$5.47K |
|
3025
Parke Bancorp
PKBK
$401M
| $575K | ﹤0.01% |
30,538
+214
| +0.7% | +$4.16K |
|
Similar funds
Charles Schwab's Q1 2025 Portfolio in Review
As of Q1 2025, Charles Schwab held 3,548 positions worth $533B, down 1.7% from $542B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.6%. Charles Schwab opened 55 new positions and exited 74, leaving the 3,548-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q1 2025 buy was iShares Currency Hedged MSCI Eurozone ETF: 7,259,426 shares worth $283M.
- Charles Schwab added most to ConocoPhillips in Q1 2025, an estimated $3.16B increase.
- Charles Schwab's biggest Q1 2025 reduction was Pfizer, cutting an estimated $2.81B.
- Charles Schwab fully exited Brookfield in Q1 2025, selling an estimated $218M.
- Charles Schwab's ten largest holdings make up 20% of its $533B portfolio in Q1 2025.
- Charles Schwab opened 55 new positions and closed 74 in Q1 2025.
- Charles Schwab's portfolio value fell 1.7% quarter-over-quarter to $533B.
Based on Charles Schwab's 13F filing for Q1 2025, filed 9 May 2025.